In 1999, HIV and AIDS was declared “a national disaster” in Kenya. The same year, however, the country took its first step toward the search for a vaccine that could end the AIDS epidemic once and for all. With support from international partners, the Kenya AIDS Vaccine Initiative (KAVI) was formed at the University of Nairobi’s School of Medicine. KAVI was the first organization in the country dedicated to AIDS vaccine research and is now a thriving research centre, with partners throughout the world. Since its founding, KAVI has conducted five clinical trials of AIDS vaccine candidates, including the first ever such trial to be conducted in the country, and several other non-clinical studies.

Click Here To Read The Full Statement